FACULTY
Edward Chu, MD
Professor of Medicine and Pharmacology
Chief, Section of Medical Oncology
Deputy Director, Yale University School of Medicine
Yale Cancer Center
DISCLOSURE OF CONFLICTS OF INTEREST
Postgraduate Institute for Medicine (PIM) assesses conflict of interest with its instructors, planners, managers, and other individuals who are in a position to control the content of CME activities. All relevant conflicts of interest that are identified are thoroughly vetted by PIM for fair balance, scientific objectivity of studies utilized in this activity, and patient care recommendations. PIM is committed to providing its learners with high-quality CME activities and related materials that promote improvements or quality in health care and not a specific proprietary business interest of a commercial interest.
The faculty reported no financial relationships or relationships to products or devices they or their spouse/life partner have with commercial interests related to the content of this CME activity.
The planners and managers reported the following financial relationships or relationships to products or devices they or their spouse/life partner have with commercial interests related to the content of this CME activity:
| Name of Planner or Manager |
Reported Financial Relationship |
| Linda Graham, RN, BSN, BA |
No real or apparent conflicts of
interest to report. |
| Joseph Cupolo, MA, MS |
No real or apparent conflicts of
interest to report. |
ACCREDITATION
STATEMENTS
Pharmacy
Postgraduate Healthcare Education, LLC is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.
Program No.: 430-000-08-026-H01-P; 430-000-08-026-H01-T
Credits: 2.0 hours (0.20 ceu)
| Published: December 1, 2008 |
Expires: December 31, 2010 |
Media:
Internet
Estimated time to complete program:
Estimated time to complete this program and posttest is 90 to 120 minutes.
ACCME Accreditation Statement
This activity has been planned and implemented in accordance with the Essential Areas and Policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint sponsorship of Postgraduate Institute for Medicine (PIM) and Postgraduate Healthcare Education, LLC. PIM is accredited by the ACCME to provide continuing medical education for physicians.
Credit Designation
Postgraduate Institute for Medicine designates this educational activity for a maximum of 1.5 AMA PRA Category 1 Credit(s)™. Physicians should only claim credit commensurate with the extent of their participation in the activity.
| Published: December 1, 2008 |
Expires: December 31, 2009 |
CNA/ANCC Accreditation Statement
This educational activity for 1.6 contact hours is provided by Postgraduate Institute for Medicine (PIM).
PIM is an approved provider of continuing nursing education by the Colorado Nurses Association, an accredited approver by the American Nurses Credentialing Center’s Commission on Accreditation.
California Board of Registered Nursing
Postgraduate Institute for Medicine is approved by the California Board of Registered Nursing, Provider Number 13485 for 1.6 contact hours.
PROCEDURE
Please complete the posttest questions and program evaluation online at: www.powerpak.com (a username and password are required to access your account). Upon passing the exam with a score of 70% or better, you can print out your statement of credit immediately. You can also view your test history at any time and print out duplicate statements from the Web site.
Exam processing inquiries and booklet orders to:
CE Customer Service Manager (800) 825-4696
Direct educational content inquiries to:
CE Director (800) 331-9396
TARGET AUDIENCE
This activity has been designed to meet the educational needs of pharmacists; pharmacy technicians; physicians, including hematologists and oncologists; and oncology nurses.
PURPOSE
The purpose of this educational activity is to develop effective strategies to manage
metastatic colorectal cancer and to improve patient adherence to therapy.
STATEMENT OF NEED/PROGRAM OVERVIEW
The goal of this educational program is to provide an update on the management of metastatic colorectal cancer, offer guidelines for appropriate selection of therapy, and provide strategies for enhancing patient adherence.
EDUCATIONAL OBJECTIVES
After completing this program, participants will be able to:
- Describe the prevalence and diagnosis of colorectal cancer; *
- Indicate the implications of nonadherence to antineoplastic therapy;*
- Outline the efficacy and safety of current agents for the management of metastatic colorectal cancer;*
- Review guidelines for appropriate selection of therapy;* and
- Describe strategies for enhancing patient adherence.
*Also applies to pharmacy technicians
Disclosure of Unlabeled Use
This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. Postgraduate Institute for Medicine (PIM), Postgraduate Healthcare Education (PHE), and Roche Laboratories/sanofi-aventis do not recommend the use of any agent outside of the labeled indications.
The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of PIM, PHE, and Roche Laboratories/sanofi-aventis. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.
Disclaimer
Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant
to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation
of their patient’s conditions and possible contraindications on dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities.
